Search research articles
Contact Us
Filters
Showing results (391-400 of 427) with videos related to
Page
of 43
Sort By:
Thorax
|
July 15, 2020
Occupational and environmental risk factors for idiopathic pulmonary fibrosis in Australia: case-control study
Michael J Abramson, Tsitsi Murambadoro, Sheikh M Alif, et al.
Respirology (Carlton, Vic.)
|
February 7, 2017
Health-related quality of life in idiopathic pulmonary fibrosis: Data from the Australian IPF Registry
Ian N Glaspole, Sally A Chapman, Wendy A Cooper, et al.
Chemical Science
|
February 15, 2020
Chronic exposure to complex metal oxide nanoparticles elicits rapid resistance in <i>Shewanella oneidensis</i> MR-1
Stephanie L Mitchell, Natalie V Hudson-Smith, Meghan S Cahill, et al.
The British Journal of Dermatology
|
December 4, 2019
What is the evidence for interactions between filaggrin null mutations and environmental exposures in the aetiology of atopic dermatitis? A systematic review
H Blakeway, V Van-de-Velde, V B Allen, et al.
Allergy
|
February 11, 2021
Sputum TNF markers are increased in neutrophilic and severe asthma and are reduced by azithromycin treatment
Natalie M Niessen, Peter G Gibson, Katherine J Baines, et al.
Epigenetics & Chromatin
|
July 1, 2016
DNA methylation signature of human fetal alcohol spectrum disorder
Elodie Portales-Casamar, Alexandre A Lussier, Meaghan J Jones, et al.
Frontiers in Immunology
|
January 1, 2026
βc receptor antagonism mitigates sarcoidosis granuloma formation by targeting inflammatory signals and aberrant lipid metabolism
Hao Wang, Damon J Tumes, Simon Keam, et al.
Lancet (London, England)
|
July 9, 2017
Effect of azithromycin on asthma exacerbations and quality of life in adults with persistent uncontrolled asthma (AMAZES): a randomised, double-blind, placebo-controlled trial
Peter G Gibson, Ian A Yang, John W Upham, et al.
Respirology (Carlton, Vic.)
|
August 29, 2017
Treatment of idiopathic pulmonary fibrosis in Australia and New Zealand: A position statement from the Thoracic Society of Australia and New Zealand and the Lung Foundation Australia
Helen E Jo, Lauren K Troy, Gregory Keir, et al.
BMC Pulmonary Medicine
|
May 5, 2019
Gastroesophageal reflux and antacid therapy in IPF: analysis from the Australia IPF Registry
Helen E Jo, Tamera J Corte, Ian Glaspole, et al.
Page
of 43
Search research articles
Search
Showing results (391-400 of 427) with videos related to
Sort By:
Page
of 43
Thorax
|
July 15, 2020
Occupational and environmental risk factors for idiopathic pulmonary fibrosis in Australia: case-control study
Michael J Abramson, Tsitsi Murambadoro, Sheikh M Alif, et al.
Respirology (Carlton, Vic.)
|
February 7, 2017
Health-related quality of life in idiopathic pulmonary fibrosis: Data from the Australian IPF Registry
Ian N Glaspole, Sally A Chapman, Wendy A Cooper, et al.
Chemical Science
|
February 15, 2020
Chronic exposure to complex metal oxide nanoparticles elicits rapid resistance in <i>Shewanella oneidensis</i> MR-1
Stephanie L Mitchell, Natalie V Hudson-Smith, Meghan S Cahill, et al.
The British Journal of Dermatology
|
December 4, 2019
What is the evidence for interactions between filaggrin null mutations and environmental exposures in the aetiology of atopic dermatitis? A systematic review
H Blakeway, V Van-de-Velde, V B Allen, et al.
Allergy
|
February 11, 2021
Sputum TNF markers are increased in neutrophilic and severe asthma and are reduced by azithromycin treatment
Natalie M Niessen, Peter G Gibson, Katherine J Baines, et al.
Epigenetics & Chromatin
|
July 1, 2016
DNA methylation signature of human fetal alcohol spectrum disorder
Elodie Portales-Casamar, Alexandre A Lussier, Meaghan J Jones, et al.
Frontiers in Immunology
|
January 1, 2026
βc receptor antagonism mitigates sarcoidosis granuloma formation by targeting inflammatory signals and aberrant lipid metabolism
Hao Wang, Damon J Tumes, Simon Keam, et al.
Lancet (London, England)
|
July 9, 2017
Effect of azithromycin on asthma exacerbations and quality of life in adults with persistent uncontrolled asthma (AMAZES): a randomised, double-blind, placebo-controlled trial
Peter G Gibson, Ian A Yang, John W Upham, et al.
Respirology (Carlton, Vic.)
|
August 29, 2017
Treatment of idiopathic pulmonary fibrosis in Australia and New Zealand: A position statement from the Thoracic Society of Australia and New Zealand and the Lung Foundation Australia
Helen E Jo, Lauren K Troy, Gregory Keir, et al.
BMC Pulmonary Medicine
|
May 5, 2019
Gastroesophageal reflux and antacid therapy in IPF: analysis from the Australia IPF Registry
Helen E Jo, Tamera J Corte, Ian Glaspole, et al.
Page
of 43